Trial intelligence / Profile preview

Intra-abdominal Ropivacaine Infusions Following LVHR

NCT02785276Withdrawn

Sponsor
The University of Auckland
Start
Aug 2016
Primary completion
Aug 2017
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, double-blind trial in postoperative pain comparing Ropivacaine infusion with Placebo infusion (2 arms). Primary endpoint: Total opiate consumption at 24 hours. Planned start Aug 2016; status: withdrawn.

02

Drugs

ropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02785276.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02785276.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call